Listen

Description

The data necessary to achieve the promise of precision medicine are now available with low-cost whole-genome sequencing, microbiome analysis, proteomics, and other large datasets. Bioscope has developed a team of AI personas to help clinicians realize that promise in a way that will revolutionize the practice of medicine.

In this episode, Sandy Vance speaks with Don Brown, MD, Founder and CEO of Bioscope, about how AI and large-scale biological data are converging to make precision medicine practical for clinicians. They explore Don’s entrepreneurial journey, the origins of Bioscope, and how a subscription-based, clinician-first approach is shaping the future of personalized care.

In this episode, they talk about:

A Little About Don:

Don Brown, MD, is a serial software entrepreneur, physician, and leader in precision medicine. Over his career, he has founded and scaled multiple groundbreaking technology companies, including Software Artistry, Interactive Intelligence, LifeOmic, and most recently Bioscope.AI. His companies have collectively generated billions in value through public offerings and acquisitions by organizations such as IBM, Genesys, and Fountain Life. In addition to his entrepreneurial work, Don is an active advisor, investor, and philanthropist, including a $30 million gift that established the Brown Immunotherapy Center at Indiana University School of Medicine.

Don holds a bachelor’s degree in physics and a master’s degree in computer science from Indiana University, an MD from Indiana University School of Medicine, and a master’s degree in biotechnology from Johns Hopkins University. A lifelong learner, he is fluent in multiple languages, an instrument-rated pilot, an avid outdoorsman, and the author of Understanding Life. He currently serves as Founder and CEO of Bioscope.AI, where he is focused on transforming how clinicians use data to deliver personalized care.